UW-Madison Professor Sterling Johnson leads one of the world’s largest and longest-running studies of people at risk for Alzheimer’s disease. His team aims to diagnose the disease years before people develop symptoms and then identify ways to slow its progression.
“A key problem we are trying to solve is how we can diagnose the disease earlier, before people even develop symptoms,” Johnson said during a campus news conference. “Early diagnosis allows time for individuals and their families to take control of their situation, maintain good quality of life, take steps to protect brain health and learn about treatments.”